封面
市場調查報告書
商品編碼
1417394

全球 HbA1c 測試市場:趨勢、預測、競爭分析(~2030 年)

HbA1c Testing Market Report: Trends, Forecast and Competitive Analysis to 2030

出版日期: | 出版商: Lucintel | 英文 150 - page report | 商品交期: 3個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

HbA1c 檢測趨勢與預測

預計到 2030 年,全球 HbA1c 檢測市場規模將達到約 34 億美元,2024 年至 2030 年年複合成長率為 12.5%。該市場的主要促進因素是糖尿病盛行率的增加和血糖控制意識的提高。全球 HbA1c 檢測市場的未來看起來充滿希望,醫院/診所、診斷實驗室、居家醫療和研究市場都充滿機會。

HbA1c 測試市場洞察

Lucintel 預測,比濁免疫檢測可提供準確的結果且具有成本效益,預計將在預測期內實現最高成長。

由於老年人口的增加,預計醫院和診所仍將是該市場的最大部分。

由於研究和宣傳宣傳活動等活動的增加,預計該地區在預測期內仍將是最大的地區。

常問問題

Q1.市場規模有多大?

A1. 到 2030 年,全球 HbA1c 檢測市場預計將達到 34 億美元。

Q2.市場成長預測如何?

A2. 2024年至2030年,全球HbA1c檢測市場預計將以12.5%的年複合成長率成長。

Q3.影響市場成長的主要促進因素有哪些?

A3. 此市場的主要促進因素是糖尿病盛行率的增加和血糖控制意識的提高。

Q4.市場的主要細分市場是什麼?

A4.HbA1c 檢測市場的未來性充滿希望,醫院/診所、診斷實驗室、居家醫療和研究機構市場都有機會。

Q5.市場上主要企業有哪些?

A5.HbA1c檢測的主要企業如下。

  • Abbott
  • Bio-Rad Laboratories
  • ARKRAY
  • Danaher
  • F. Hoffmann-La Roche

Q6.未來最大的細分市場是什麼?

A6.Lucintel 預測,比濁免疫檢測可提供準確的結果且具有成本效益,將在預測期內達到最高的成長。

Q7. 未來五年預計哪個地區將成為最大的市場?

A7. 由於該地區研究和宣傳宣傳活動等活動的增加,預計北美在預測期內仍將是最大的地區。

Q8. 可以客製化報告嗎?

A8. 是的,Lucintel 提供 10% 的客製化服務,無需額外付費。

目錄

第1章執行摘要

第2章全球 HbA1c 檢測市場:市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 市場趨勢及預測分析(2018-2030)

  • 宏觀經濟趨勢(2018-2023)與預測(2024-2030)
  • 全球 HbA1c 檢測市場趨勢(2018-2023)與預測(2024-2030)
  • 全球 HbA1c 測試市場:按類型
    • 裝置
    • 試劑
    • 套件
  • 全球 HbA1c 測試市場:依技術分類
    • 離子交換高效液相層析法
    • 酵素測定
    • 親和性和結合層析法
    • 比濁免疫免疫檢測
    • 其他
  • 全球 HbA1c 測試市場:依最終用途分類
    • 醫院/診所
    • 診斷實驗室
    • 居家護理
    • 研究機構
    • 其他

第4章市場趨勢與預測分析:按地區(2018-2030)

  • 全球 HbA1c 測試市場:按地區
  • 北美洲
  • 歐洲
  • 亞太地區
  • 其他地區

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 按類型
    • 依技術
    • 按最終用途
    • 按地區
  • 全球 HbA1c 檢測市場的新興趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球 HbA1c 檢測市場的容量
    • 全球 HbA1c 檢測市場的合併、收購與合資
    • 認證和許可

第7章主要企業概況

  • Abbott
  • Bio-Rad Laboratories
  • ARKRAY
  • Danaher
  • F. Hoffmann-La Roche
簡介目錄

HbA1c Testing Trends and Forecast

The future of the global HbA1c testing market looks promising with opportunities in the hospital &clinic, diagnostic laboratorie, homecare, and research institution markets. The global HbA1c testing market is expected to reach an estimated $3.4 billion by 2030 with a CAGR of 12.5% from 2024 to 2030. The major drivers for this market are growing incidence of diabetes and increasing awareness regarding glycemic control.

A more than 150-page report is developed to help in your business decisions.

HbA1c Testing by Segment

The study includes a forecast for the global HbA1c testing by type, technology, end use, and region.

HbA1c Testing Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Instruments
  • Reagents
  • Kits

HbA1c Testing Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

  • Ion-Exchange HPLC
  • Enzymatic Assay
  • Affinity Binding Chromatography
  • Turbidimetric Inhibition Immunoassay
  • Others

HbA1c Testing Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals and Clinics
  • Diagnostic Laboratories
  • Homecare
  • Research Institution
  • Others

HbA1c Testing Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of HbA1c Testing Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies HbA1c testing companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the HbA1c testing companies profiled in this report include-

  • Abbott
  • Bio-Rad Laboratories
  • ARKRAY
  • Danaher
  • F. Hoffmann-La Roche

HbA1c Testing Market Insights

Lucintel forecasts that turbidimetric inhibition immunoassay is expected to witness the highest growth over the forecast period as it delivers accurate results and are cost effective.

Within this market, hospital & clinic will remain the largest segment due to growing geriatric population.

North America will remain the largest region over the forecast period due to increase in number of activities like esearch and awareness campaigns in the region.

Features of the Global HbA1c Testing Market

Market Size Estimates: HbA1c testing market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: HbA1c testing market size by type, technology, end use, and region in terms of value ($B).

Regional Analysis: HbA1c testing market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, technologies, end uses, and regions for the HbA1c testing market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the HbA1c testing market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the HbA1c testing market size?

Answer: The global HbA1c testing market is expected to reach an estimated $3.4 billion by 2030.

Q2. What is the growth forecast for HbA1c testing market?

Answer: The global HbA1c testing market is expected to grow with a CAGR of 12.5% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the HbA1c testing market?

Answer: The major drivers for this market are growing incidence of diabetes and increasing awareness regarding glycemic control.

Q4. What are the major segments for HbA1c testing market?

Answer: The future of the HbA1c testing market looks promising with opportunities in the hospital &clinic, diagnostic laboratory, homecare, and research institution markets.

Q5. Who are the key HbA1c testing market companies?

Answer: Some of the key HbA1c testing companies are as follows.

  • Abbott
  • Bio-Rad Laboratories
  • ARKRAY
  • Danaher
  • F. Hoffmann-La Roche

Q6. Which HbA1c testing market segment will be the largest in future?

Answer: Lucintel forecasts that turbidimetric inhibition immunoassay is expected to witness the highest growth over the forecast period as it delivers accurate results and are cost effective.

Q7. In HbA1c testing market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to increase in number of activities like esearch and awareness campaigns in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the HbA1c testing market by type (instruments, reagents, and kits), technology (ion exchange HPLC, enzymatic assay, affinity binding chromatography, turbidimetric inhibition immunoassay, and others), end use (hospitals and clinics, diagnostic laboratories, homecare, research institution, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global HbA1c Testing Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global HbA1c Testing Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global HbA1c Testing Market by Type
    • 3.3.1: Instruments
    • 3.3.2: Reagents
    • 3.3.3: Kits
  • 3.4: Global HbA1c Testing Market by Technology
    • 3.4.1: Ion Exchange HPLC
    • 3.4.2: Enzymatic assay
    • 3.4.3: Affinity Binding Chromatography
    • 3.4.4: Turbidimetric Inhibition Immunoassay
    • 3.4.5: Others
  • 3.5: Global HbA1c Testing Market by End Use
    • 3.5.1: Hospitals and Clinics
    • 3.5.2: Diagnostic Laboratories
    • 3.5.3: Homecare
    • 3.5.4: Research Institution
    • 3.5.5: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global HbA1c Testing Market by Region
  • 4.2: North American HbA1c Testing Market
    • 4.2.1: North American HbA1c Testing Market by Technology: Ion Exchange HPLC, Enzymatic assay, Affinity Binding Chromatography, Turbidimetric Inhibition Immunoassay, and Others
    • 4.2.2: North American HbA1c Testing Market by End Use: Hospitals and Clinics, Diagnostic Laboratories, Homecare, Research Institution, and Others
  • 4.3: European HbA1c Testing Market
    • 4.3.1: European HbA1c Testing Market by Technology: Ion Exchange HPLC, Enzymatic assay, Affinity Binding Chromatography, Turbidimetric Inhibition Immunoassay, and Others
    • 4.3.2: European HbA1c Testing Market by End Use: Hospitals and Clinics, Diagnostic Laboratories, Homecare, Research Institution, and Others
  • 4.4: APAC HbA1c Testing Market
    • 4.4.1: APAC HbA1c Testing Market by Technology: Ion Exchange HPLC, Enzymatic assay, Affinity Binding Chromatography, Turbidimetric Inhibition Immunoassay, and Others
    • 4.4.2: APAC HbA1c Testing Market by End Use: Hospitals and Clinics, Diagnostic Laboratories, Homecare, Research Institution, and Others
  • 4.5: ROW HbA1c Testing Market
    • 4.5.1: ROW HbA1c Testing Market by Technology: Ion Exchange HPLC, Enzymatic assay, Affinity Binding Chromatography, Turbidimetric Inhibition Immunoassay, and Others
    • 4.5.2: ROW HbA1c Testing Market by End Use: Hospitals and Clinics, Diagnostic Laboratories, Homecare, Research Institution, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global HbA1c Testing Market by Type
    • 6.1.2: Growth Opportunities for the Global HbA1c Testing Market by Technology
    • 6.1.3: Growth Opportunities for the Global HbA1c Testing Market by End Use
    • 6.1.4: Growth Opportunities for the Global HbA1c Testing Market by Region
  • 6.2: Emerging Trends in the Global HbA1c Testing Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global HbA1c Testing Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global HbA1c Testing Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Abbott
  • 7.2: Bio-Rad Laboratories
  • 7.3: ARKRAY
  • 7.4: Danaher
  • 7.5: F. Hoffmann-La Roche